Understanding the patient journey in an under-diagnosed urological condition

The challenge

  • Understand patient journey from symptoms to diagnosis and treatment, including language used and emotional impact

  • Validate diagnosis and treatment rates

  • Quantify patient pathways, time to treatment, HCPs seen and size of population likely to benefit from/use new product

The approach

  • Face-to-face, in-depth interviews with patients in 3 EU countries

  • Screening of large consumer panels to validate prevalence of condition

  • Extended screening of those with the condition to validate diagnosis & treatment rates

  • Detailed online survey among potential candidates for the new product

 
pp_case_studies_icon_pills_01a.png
 

Purdie Pascoe value added

  • Prior knowledge and experience of therapy area

  • Purdie Pascoe director with industry-side experience heavily involved throughout

  • Shared words/phrases used to describe symptoms and feelings in local languages 

  • Populated and further developed a forecast tool

Business Impact

“The findings from this research have provided some great insights to assist the communications agency as well as robust data to enable market sizing and forecasting.” 

Senior Manager, Market Research

Our Senior Pharmaceuticals Team:

Previous
Previous

Conjoint research to assess the potential of a new product in ophthalmology

Next
Next

Patient ethnography to evaluate the packaging of a biosimilar in Rheumatoid Arthritis